144 ·Filed Jun 11, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001950047-26-005928
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-withholding sale tied to vesting — no bearish signal. Monitor for any unplanned open-market sales by Oyler in coming weeks; the 06/08 sale of 4,940 ADSs was larger but still modest relative to his position. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
ONC ▲ +32.89% at T+60d
NEUTRAL call ✓ call won +32.89% · α vs SPY +29.63% · entry $264.48 → $351.48
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
+1.41%
call +1.41% · α -0.36%
$268.20
settled 4mo ago
T+5d
+2.14%
call +2.14% · α +1.47%
$270.15
settled 4mo ago
T+20d
+12.94%
call +12.94% · α +11.16%
$298.70
settled 3mo ago
T+60d
+32.89%
call +32.89% · α +29.63%
$351.48
settled 24d ago

Price Chart

Loading chart...

Executive Summary

Director John Oyler filed a Form 144 notice of intent to sell 1,949 ADSs (~$501K) of BeOne Medicines Ltd. (ONC), with proceeds going to cover tax withholding on restricted stock vesting. The sale is a routine tax-motivated disposition, not a discretionary portfolio reduction, and represents a negligible fraction of Oyler's total holdings.

Key Facts

  • John Oyler (Director) filed Form 144 to sell 1,949 ADSs on 2026-06-11.
  • Estimated proceeds: ~$501,355 (based on 06/10/2026 price).
  • Sale is for tax withholding on restricted stock vesting under a registered plan.
  • Oyler also sold 4,940 ADSs on 06/08/2026 (~$1.34M), bringing recent total to ~$1.84M.
  • The 1,949 ADS sale is ~0.003% of ONC's $29.3B market cap.

Financial Impact

~$501K in proceeds from 1,949 ADSs; tax-motivated, not discretionary.

insider holdings

Risk Factors

  • If Oyler files additional Form 144s for open-market sales beyond tax withholding, it could signal reduced conviction.
  • Historical model performance on ONC is poor (avg T+20 -14%), suggesting limited predictive value from insider filings here.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005928
Document: 0001950047-26-005928-index.html0001950047-26-005928
Document: 0001950047-26-005928.txt0001950047-26-005928
19 reports for ONC
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +10.46%Aug 5, 2026
Filters
Rows
Reports for ONC — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Insider Cluster
NEUTRAL ★ 3/10
$346.51 $350.84▲ +1.25%▲ +1.47%$358.07 (+3.34%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$362.68 $346.51▼ −4.46%▼ −3.31%$358.07 (−1.27%)
Aug 26, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$375.80 $361.78▼ −3.73%▼ −3.61%$358.07 (−4.72%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$347.48 $374.47▲ +7.77%▲ +9.14%$358.07 (+3.05%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$356.01 $369.16▲ +3.69%▲ +5.66%$358.07 (+0.58%)
Aug 10, 2026
7w ago
144
BEARISH ★ 6/10
$359.27 $369.15▼ −2.75%▼ −3.15%$358.07 (+0.33%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$329.80 $356.01▲ +7.95%▲ +6.73%$358.07 (+8.57%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$327.53 $359.05▲ +9.62%▲ +9.27%$358.07 (+9.32%)
Jul 24, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$325.90 $322.08▼ −1.17%▼ −1.55%$358.07 (+9.87%)
Jul 17, 2026
11w ago
Insider Cluster
BEARISH ★ 5/10
$312.02 $326.77▼ −4.73%▼ −5.41%$358.07 (−14.76%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (64h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access